Latest FDA Stories
FDA approves new uses of lenalidomide and panobinostat WHITE PLAINS, N.Y., Feb. 26, 2015 /PRNewswire-USNewswire/ --Two recent approvals by the U.S.
- Treatment for Adult Patients with Complicated Intra-abdominal infections (cIAI) and Complicated Urinary Tract Infections (cUTI) - DUBLIN, Feb.
FDA and EFSA Assessments Clearly State that BPA is Safe WASHINGTON, Feb.
Proceeds to fund manufacturing, sales and marketing programs for LabStyle's Dario(TM) as well as ongoing FDA efforts CAESAREA, Israel, Feb.
Myanmar Medical Exhibition | Myanmar Pharmaceutical Exhibition | Myanmar Medical Equipment Show | Myanmar Medical Devices Exhibition | Myanmar Cosmetics Exhibition | Myanmar Cosmo Beauty Spa Product
PARSIPPANY, N.J., Feb. 25, 2015 /PRNewswire/ -- GlaxoSmithKline (GSK) Consumer Healthcare announced today the return of alli® (orlistat 60 mg capsules) to most stores in the U.S.
EATONTOWN, N.J., Feb. 25, 2015 /PRNewswire/ -- Heritage Pharmaceuticals Inc.
Celgene Launches Psoriatic Arthritis Educational Patient-Focused Program SUMMIT, N.J., Feb.
Lawsuit website reports recent announcement by Bayer and Johnson & Johnson that they will push for further FDA approvals for Xarelto, while lawsuits against them are consolidated in multidistrict litigation
ARM requests additional clarity on a number of points within the guidance and recommends the FDA hold a public hearing to facilitate discussion with stakeholders. WASHINGTON,
- A person in a secondary role, specifically the second most important character (after the protagonist).